Heerlen, NL, 23-11-2012 — /europawire.eu/ — Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has reached an agreement with Borealis AG for the sale of DEXPlastomers V.o.F, a 50/50 Joint Venture of DSM with an affiliate of ExxonMobil Chemical. DSM will also sell its LldPE Compact Solution Technology to Borealis. Subject to customary approvals and notifications, the transaction is expected to close in Q1 2013.
Established in 1996, DEXPlastomers is a 50/50 joint venture between DSM and Exxon Chemical Holland Ventures B.V., producing C8 plastomers and linear low density polyethylene. DSM’s LldPE Compact Solution Technology was developed in the 1960’s to produce polyethylenes in a certain density range and is instrumental to the operations of DEXPlastomers.
In 2012, DEXPlastomers anticipates sales of approximately €180 million. Currently, 95 DSM employees are in the scope of the transaction.
For DSM, a sale of DEXPlastomers is in line with its long-term focus of being a Life Sciences and Materials Sciences company, active in health, nutrition and materials. DSM’s 50% participation in DEXPlastomers is reported under Corporate Activities in DSM’s accounts.
###
Contact
For more Information:
DSM Corporate Communications
Herman Betten
tel. +31 (0)45 578 2017
media.relations@dsm.com
DSM Investor Relations
Dave Huizing
tel. +31 (0)45 578 2864
investor.relations@dsm.com
(IN BRIEF) Ioannis Tsakiris, a former Greek deputy minister with extensive experience in finance and…
(IN BRIEF) Eviden, a leading business within the Atos Group specializing in advanced computing, introduces…
(IN BRIEF) Eviden, a digital, cloud, big data, and security business within the Atos Group,…
(IN BRIEF) Airbus Helicopters has secured a contract with the Ministry of Defence of Brunei…
(IN BRIEF) Ørsted's interim report for the first quarter of 2024 reveals operating profit in…
(IN BRIEF) Omexom UK & RoI and Taylor Woodrow, subsidiaries of VINCI Energies and VINCI…